Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for MCRXF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2021. Start Trial.
Date Value
July 31, 2026 99.66%
June 30, 2026 99.66%
May 31, 2026 99.66%
April 30, 2026 99.66%
March 31, 2026 99.66%
February 28, 2026 99.66%
January 31, 2026 99.66%
December 31, 2025 93.88%
November 30, 2025 93.88%
October 31, 2025 93.88%
September 30, 2025 93.88%
August 31, 2025 93.88%
July 31, 2025 93.88%
June 30, 2025 90.83%
May 31, 2025 90.83%
April 30, 2025 90.83%
March 31, 2025 90.83%
February 28, 2025 90.83%
January 31, 2025 90.83%
December 31, 2024 90.83%
November 30, 2024 90.83%
October 31, 2024 90.83%
September 30, 2024 90.83%
August 31, 2024 84.71%
July 31, 2024 81.04%
Date Value
June 30, 2024 81.04%
May 31, 2024 79.51%
April 30, 2024 76.15%
March 31, 2024 76.15%
February 29, 2024 76.15%
January 31, 2024 76.15%
December 31, 2023 75.54%
November 30, 2023 75.54%
October 31, 2023 75.54%
September 30, 2023 75.54%
August 31, 2023 75.54%
July 31, 2023 75.54%
June 30, 2023 75.54%
May 31, 2023 75.54%
April 30, 2023 75.54%
March 31, 2023 75.54%
February 28, 2023 75.54%
January 31, 2023 0.00%
December 31, 2022 0.00%
November 30, 2022 0.00%
October 31, 2022 0.00%
September 30, 2022 0.00%
August 31, 2022 0.00%
July 31, 2022 0.00%
June 30, 2022 0.00%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Cochlear Ltd. 71.44%
ImpediMed Ltd. 98.50%
Nanosonics Ltd. 72.61%
Somnomed Ltd. 94.01%
Imagion Biosystems Ltd. 99.93%